Home Blog

Gaensel Energy Group, Inc. (GEGR) Announces Investment in Media Group, Le Roy srl and New Energy Contract

0

Salt Lake City, Utah–(Newsfile Corp. – September 27, 2022) – Gaensel Energy Group, Inc., (OTC Pink: GEGR) (“Gaensel” or the “Company”), a diversified holding company, announces a corporate update.

On August 5 GEGR acquired 50% of a group of Italian magazines owns by Le Roy srl. Group Editorial Le Roy was founded on 2003 by the editor and experienced journalist Dario Bordet.

Le Roy Group owns and manage 2 magazines Italia da gustare, http://www.italiadagustare.it, and 24News, http://www.24orenews.it , with revenues in 2021 exceeding 1 Million Euros.

This acquisition will provide additional media and advertising components for our Company and the Le Roy staff will operate from the headquarters of our GATE SRL in via Pasquale Sottocorno, Milano Italy.

GATE SRL in now printing 6,000 copies per month and is distributed in all the Italian airports. Gate, with the financial support of GEGR, if finalizing its contracts and mobile application to advertise and promote retail and marketing activities in the European airport markets and contract as the exclusive media agent for all the Italian airports.

Our Consortium Green Energy group, LB Energy, has completed a contract with Italian Cable Company (ICC SPA) to produce copper wire cable which will generate monthly revenues exceeding $1 Million USD.

About Gaensel Energy Group, Inc. (OTC Pink: GEGR):

Gaensel Energy Group asset base currently consists of proven companies in Biotech, Commodities, Health, Beauty – Fashion, Green and Renewable Energy, and Technology. The management teams for each of these divisions are actively seeking similar partners in each space for expansion and additional acquisitions. We have been listed on the United States OTC Markets since 2002 and the Company is current.

Gaensel Energy Group, Inc.
57 West 200 South
Suite 300
Salt Lake City, UT 84101
[email protected]
Phone: +1 518-567-3649
https://www.gegrgroup.com
https://twitter.com/gegrgroup

Forward-looking statements

This document contains certain forward-looking statements with respect to the financial condition, results of operations and business of Gaensel Energy Group, Inc., (GEGR), and certain of the plans and objectives of GEGR with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future EBITA and future developments in our organic business. Forward-looking statements can be identified generally as those containing words such as “anticipates”, “assumes”, “believes”, “estimates”, “expects”, “should”, “will”, “will likely result”, “forecast”, “outlook”, “projects”, “may” or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

These factors include, but are not limited to, domestic and global economic and business conditions, the successful implementation of our strategy and our ability to realize the benefits of this strategy, our ability to develop and market new products, changes in legislation, legal claims, changes in exchange and interest rates, changes in tax rates, pension costs and actuarial assumptions, raw materials and employee costs, our ability to identify and complete successful acquisitions and to integrate those acquisitions into our business, our ability to successfully exit certain businesses or restructure our operations, the rate of technological changes, political, economic and other developments in countries where GEGR operates, industry consolidation and competition. As a result, GEGR actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138590

The Gummy Project Achieves Another Milestone with Purchase Order from Canada Life Centre, Home of the National Hockey League’s Winnipeg Jets and American Hockey League’s Manitoba Moose

0

  • Purchase from an NHL sports and entertainment venue marks an important milestone in The Gummy Project’s multi-channel sales strategy.
  • The Gummy Project’s Peachy Bees and Watermelon Sharks will be featured for sale in all concessions, starting with the Winnipeg Jets pre-season home opener.
  • Peachy Bees and Watermelon Sharks now available in an NHL sports and entertainment venue, major grocery chains, a national airline, hotels (in both US and Canada) and one of the largest passenger ferry lines in the world.

Vancouver, British Columbia–(Newsfile Corp. – September 27, 2022) – The Gummy Project (CSE: GUMY) (FSE: 0OS0) (OTCQB: GUMYF) (“GUMY” or the “Company”) is pleased to announce it has received a purchase order from The Canada Life Centre, home of the National Hockey League’s Winnipeg Jets and American Hockey League’s Manitoba Moose.

“We are absolutely thrilled that our Peachy Bees and Watermelon Sharks will be available for fans to enjoy at Jets and Moose games,” said Charlie Lamb, President & CEO of GUMY. “Our multi-channel sales strategy now includes high traffic sports and entertainment venues, with Canada Life Centre marking our entrance into this sector and a key milestone for the Company. In a very short time period, we have been able to form partnerships with and have our gummies for sale in major grocery chains, a national airline, hotels (both in the US and Canada), one of the largest passenger ferry systems in the world and now a professional sports stadium and we very much look forward to continuing to execute our strategic expansion both in Canada and the US.”

Canada Life Centre (formerly MTS Centre and Bell MTS Place) is an indoor arena in downtown Winnipeg, Manitoba. The arena is the home to the National Hockey League’s Winnipeg Jets and their American Hockey League affiliate, the Manitoba Moose. The arena stands on the former Eaton’s site and is owned and operated by True North Sports & Entertainment. The 440,000 square building was constructed opened on November 16, 2004, replacing the since-demolished Winnipeg Arena. It has a capacity of 15,321 for hockey and 16,345 for concerts.

“Being born in Winnipeg myself, it’s a dream come true to know that our gummies will be sold at Winnipeg Jets games,” said Anthony Gindin, CMO of GUMY. “This also marks our expansion into the exciting new sales vertical of sports and entertainment venues.”

About The Gummy Project

We are a growing community of individuals and organizations who believe small contributions can add up to something big. We sell low sugar, plant based gummy products while raising money (and awareness) to support endangered keystone species. We are the only “better for you” candy company that is built to support our planet’s most precious species and ecosystems, while educating our future generations on the steps we must take today, to ensure a viable tomorrow.

Charlie Lamb, President & CEO, Director
Telephone: 1(236) 317-2812 – Toll free 1(888) 556-9656
E-mail: [email protected]

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates”, “may” or “believes” or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, risks relating to epidemics or pandemics such as COVID-19, including the impact of COVID-19 on the Company’s business, financial condition, and results of operations. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138511

Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers

0
  • Syndicate marketplace showcases a variety of specially curated products and formats made in-house and/or sourced from micro-cultivators looking for a medical distribution outlet
  • As a supplemental market to insured benefits channel Starseed Medicinal, Syndicate will offer clients sans insurance access a variety of brand favourites including Color & Saturday Cannabis

TORONTO, Sept. 27, 2022 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the launch of Syndicate a direct-to-patient medical cannabis marketplace showcasing a portfolio of premium craft cannabis products sourced both in-house and from third-party micro-cultivators and producers. The Company is one of the first to launch a medical-marketplace collective of craft producers.

Syndicate complements the Company’s popular medical platform Starseed Medicinal which specializes as a medical cannabis provider to clients with insurance benefits coverage. With Syndicate, patients without insurance coverage can access a comprehensive catalogue of cannabis products, formats, and brands at a competitive price point. A unique model that offers an assortment of products from various producers, including partnerships with Greenseal Cannabis, Sitka Micro, Premium 5 and QWest Cannabis; a collective of micro-cultivators looking to distribute small-batch brands into the medical channel.

“Launching Syndicate as a supplementary medical marketplace has been a long-time passion project for many of us at Entourage because it reinforces our commitment to providing optimal patient care with access to locally produced, quality cannabis products within a framework of affordability,” said Nikki Thomas, Marketing Director, Entourage. “Additionally, in supporting craft producers with a medical outlet to share their unique offerings with our patients, we are taking our medical business to the next level. Our Syndicate clients will have the same patient-centric services currently offered to our Starseed clients – all rooted in innovation, technology and education. Empowering our patients with a seamless online process and access to world-class customer service provides for a safe and responsible entry-point.”

“The original purpose for launching our Company in 2013 harkens back to our deep-seeded belief that medical cannabis as a wellness option should be made available to all eligible Canadians and we are proud to be partnering with these micro-cultivators and licensed producers who share in this mission,” said George Scorsis, CEO and Executive Chairman, Entourage. “With Syndicate, we are returning to our roots with access to medical cannabis at the heart of our purpose. We continue to advocate for cannabis medicine to be an insured benefit, but we know the reality is that not all our clients have access and this channel is dedicated to those patients.”

Canadian medical patients in Ontario (with more provinces to be added) can now register as Syndicate patients here. With more than 50 products from over five local producers expected to be available, patients may select unique products such as infused pre-rolls, topical compounds, oils, vapes, edibles, dried flower products and soon, cannabis-infused beverages ‘TeaPot’. Additionally, Syndicate offers a compassionate pricing program and fast and convenient shipping options.

Syndicate will handle the customer service, online payments and fulfillment as Entourage continues to bring many other partners into the fold in the coming months.

Visit Entourage’s website here to access the latest Company updates.

About Entourage Health Corp.

Entourage Health Corp. is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a state-of-the-art hybrid greenhouse and processing facility located on 158-acres in Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON processing facility, specializing in cannabis extraction; and a micropropagation, tissue culture and genetics centre-of-excellence in Guelph, Ontario. With its Starseed Medicinal medical-centric brand and marketplace, Entourage has an industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, who together with employers and other union groups, facilitate access for insured medical patients. With the launch of Syndicate, the Company now hosts another unique medical marketplace that offers patients a collective of Canadian micro-cultivators’ products, along with the Company’s family of brands. Entourage’s elite adult-use product portfolio includes Color Cannabis, Saturday Cannabis and Royal City Cannabis Co.– sold across eight provincial distribution agencies. It is the exclusive Canadian producer and distributor of award-winning U.S.-based wellness brand Mary’s Medicinals sold in both medical and adult-use channels. Under a collaboration with The Boston Beer Company subsidiary, Entourage is also the exclusive distributor of cannabis-infused beverages ‘TeaPot’ in Canada, which launched in select provinces summer 2022.

For more information, please visit us at: www.entouragehealthcorp.com

Follow Entourage and its brands on: LinkedIn

Twitter: Entourage, Color Cannabis, Saturday Cannabis, Starseed, Royal City Cannabis Co. & Syndicate

Instagram: Entourage, Color Cannabis, Saturday Cannabis, Starseed, Royal City Cannabis Co. & Syndicate

For further information, investor or media inquiries, please contact:

Marianella delaBarrera
SVP, Communications & Corporate Affairs
416-897-6644
[email protected]
[email protected]
[email protected]

Forward Looking Information: This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation which are based upon Entourage’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as “expect”, “likely”, “may”, “will”, “should”, “intend”, “anticipate”, “potential”, “proposed”, “estimate” and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions “may”, “would” or “will” happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of Entourage to implement its business strategies; the COVID-19 pandemic; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Entourage does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Entourage to predict all such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in Entourage’s disclosure documents filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Psyched Wellness Announces Successful Pilot Run, Final Flavour Profile for Calm and Shipping Pre-Orders in October

0

Toronto, Ontario–(Newsfile Corp. – September 27, 2022) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched”), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is pleased to announce positive feedback from test subjects who participated in the pilot run of 300 bottles of Calm. This feedback provided the company with the necessary information to determine the final flavour formulation for Calm. Additionally, the Company is pleased to share that pre orders are now sold out and shipping will commence mid to end of October.

Key Takeaways from Pilot Run:

  • An ideal dose (for maximum effect) will range from 1ml to 2ml depending on the users familiarity with Amanita Muscaria products
  • The majority of the test subjects experienced desired effects (calming and relaxing sensation) with recommended serving
  • The majority of the test subjects felt that they woke the next day well-rested and with little to no grogginess
  • Feedback from test subjects helped identify the final flavour profile
  • Pilot run helped our CMO identify extraction efficiencies that will enhance production, increasing efficiency and lowering cost of goods

Jeffrey Stevens, CEO of the Company says, “We have taken a cautious approach to bringing our flagship product, Calm, to market. We have been working closely with Vantage Hemp, our contract manufacturer and providing them with the feedback from our test participants to ensure we produce the best version of Calm for our consumers.”

“These are very exciting times!”, says David Shisel, COO of the Company. “Shipping CALM, our Amanita Muscaria product that we are all using for our wellness, to real customers outside of our internal focus groups, marks a very significant milestone in our company’s progression. We are extremely excited for everyone to try it.”

To preorder Calm, visit shop.psyched-wellness.com.

For further information, please contact:

Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
Tel: 647-400-8494
Email: [email protected]

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

About Psyched Wellness Ltd.:

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Cautionary Statement Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to develop Amanita Muscaria-derived products; the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and (ii) the uses and potential benefits of Amanita Muscaria.

Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to continue to develop its mushroom-derived products and associated consumer packaged goods; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company.

These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the psychedelics market; risks with respect to the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and the risk that there is no potential benefit of Amanita Muscaria consumption.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138566

Cannabis Beverages Market to Reach USD 19,063.58 Million by 2028 | At a CAGR 54.31%

0

Pune, India, Sept. 27, 2022 (GLOBE NEWSWIRE) — The global cannabis beverages market size was USD 574.90 million in 2020. The market is slated to grow from USD 915.06 million in 2021 to USD 19,063.58 million in 2028 at a CAGR of 54.31% in the 2021-2028 period.

This information is provided by our researchers at Fortune Business Insights, in the report, titled, “Cannabis Beverages Market, 2021-2028.”

According to our expert analysts, the market is projected to attain traction from the rising penetration of cannabis in the unexploited consumer markets, such as Thailand and Australia, among others. Additionally, the surging consumers’ predisposition towards experimenting with novel and groundbreaking food and beverages has also improved the market performance.

Get a Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cannabis-beverages-market-100738

List of Key Players Mentioned in the Market Report:

  • Aurora Cannabis Inc. (Edmonton, Canada)
  • Aphria Inc. (Leamington, Canada)
  • Canopy Growth Corporation (Canada)
  • MedReleaf Corp. (Edmonton, Canada)
  • Cronos Group Inc. (Toronto, Canada)
  • GW Pharmaceuticals, plc. (Cambridge, U.K.)
  • CannTrust Holdings Inc. (Vaughan, Canada)
  • VIVO Cannabis Inc. (Ontario, Canada)
  • Tilray (Nanaimo, Canada)
  • OrganiGram Holdings (Moncton, Canada)

Report Scope & Segmentation:

Report Coverage Details
Forecast Period 2021-2028
Forecast CAGR 54.31%
2028 Value Projection USD 19,063.58 Million
Base Year 2020
Cannabis Beverages Market Size in 2020 USD 574.90 Million
Historical Data 2017-2019
No. of Pages 130
Segments Covered By Type, By Geography, By Distribution Channel
Cannabis Beverages Market Growth Drivers Fundamental Transformation in Beverage Industry to Support Growth
Growing HoReCa Sector and Modern Trade Practices to Proliferate Revenue

COVID-19 Impacts:

Amplified Demand for Flavorful Drinks amid COVID-19 Pandemic to Promote Growth

The COVID-19 pandemic outbreak resulted in various governments to execute stringent lockdown norms and social distancing guidelines, across the world. Market terminations, weakened eating-out trends, and constraints in public mobility resulted in the people being confined to their houses. This also instigated risen stress, panic-buying and stockpiling among the consumers during the primary stages of lockdown, which triggered the cannabis and cannabis-imparted product sales.

Browse Summary of this Research Report:

https://www.fortunebusinessinsights.com/industry-reports/cannabis-beverages-market-100738

Report Coverage:

The report presents a holistic study of the market along with current trends and upcoming estimations to institute approximate investment gains. An in-depth analysis of any forthcoming prospects, threats, competitions or driving factors are also declared in the report. Furthermore, methodical regional analysis of the market is offered.

Moreover, COVID-19 impacts have been added to the report to help investors and business owners to comprehend the jeopardies better. The top-tiered players in the market are recognized, and their tactics to reinforce the market growth are shared in the report.

Segmentation:

By type, the market is divided into:

  • Alcoholic
  • Non-alcoholic

Based on the distribution channel, the market is segregated into:

  • Mass Merchandisers
  • Specialty Stores
  • Online Retail
  • Others

On the basis of geography, the global market is separated into:

  • North America
  • Europe
  • Rest of the World

Drivers and Restraints:

Transformation of Beverages Sector to Create New Growth Opportunities

Cannabis consumers are no longer restricted to smoking flowers with joints, bongs, or pipes but have an option from a surging assortment of products, involving concentrated as well as infused products. The beverages industry in itself is experiencing an indispensable change in terms of all the ingredients and additives.

Consumers, particularly in the advanced markets of North America and Europe are persistently forming the category amidst organic and chemicals-free, and with detectible and herbal formulations trends and developments. This is anticipated to bolster the cannabis beverages market growth during the upcoming period.

Inquire Before Buying This Report: 

https://www.fortunebusinessinsights.com/enquiry/queries/cannabis-beverages-market-100738

Regional Insights:

North America is at the front position of the cannabis-infused beverages sector and holds the maximum cannabis beverages market share. This region registered for USD 527.83 million in 2020. The sector was commanded by the U.S. where the functional beverage market is unveiling a sudden growth graph.

Cannabis-based beverages have exhibited comparatively lower growth in developing regions such as Asia, Oceania, and Latin America owing to the ban of THC products in the market.

Competitive Landscape:

Radical Product Presentation by Vital Players Set to Navigate Market Growth

The prominent players in the market apply abundant tactics to fortify their position in the market as leading companies. One such considerable tactic is acquiring companies to boost the brand value among users. Another essential strategy is intermittently launching pioneering products with thorough review of the market and its target audience.

For example, in April 2021, Molecule Holdings Inc. inaugurated Molecule Crafted, which is a cannabis-infused craft beverage assortment in Canada. These cannabis beverages are low in calories and accessible in various exotic as well as bold flavors.

Industry Developments:

August 2021 – Cann, who is a THC beverage manufacturer based in California, stated the launch of Passion Peach Mate, an exclusive and novel caffeinated cannabis beverage. The manufacturer presented this product series to provide all-natural caffeine with a micro dose of THC to the users as they hunt for substitutions to alcoholic beverages.

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market SegHouseholdtation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Emerging Trends
  • Key Insights
    • Overview on Global Cannabis Market
    • Supply Chain & Regulatory Analysis
    • Global Cannabis Beverages Regulatory Analysis
    • Recent Industry DevelopHouseholdts – Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
    • Qualitative Analysis (in Relation with COVID-19)
      • Impact of COVID-19
      • Challenges in Supply Chain
      • Efforts to Mitigate the Challenges
  • Global Cannabis Beverages Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Size Estimates and Forecast 
      • By Type (Value)
        • Alcoholic
        • Non-alcoholic
      • By Distribution Channel (Value)
        • Mass Merchandisers
        • Specialty Stores
        • Online Store
        • Others
      • By Region (Value)
        • North America
        • Europe
        • Rest of the World
  • North America Cannabis Beverages Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Size Estimates and Forecast 
      • By Type (Value)
        • Alcoholic
        • Non-alcoholic
      • By Distribution Channel (Value)
        • Mass Merchandisers
        • Specialty Stores
        • Online Store
        • Others
      • By Country (Value)
        • U.S
          • By Type (Value)
            • Alcoholic
            • Non-alcoholic
        • Canada
          • By Type (Value)
            • Alcoholic
            • Non-alcoholic

TOC Continued…!       

Speak to Our Expert:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cannabis-beverages-market-100738

Read Related Insights:

Cannabis Market to Hit $197.74 Billion by (2021-2028) | Marijuana Industry CAGR of 32.04%

CBD Hemp Oil Market to Worth $55,791.3 Million [2021-2028] | Cannabidiol Industry Share, Revenue, and Forecast Report by Fortune Business Insights™

Hops Market Share, Size, Growth, Regional Insights by 2029 | Increasing Demand for Different Variety of Flowers by Cosmetic Industry Will Aid Growth

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights Pvt. Ltd.

9th Floor, Icon Tower,

Baner – Mahalunge Road, Baner,

Pune-411045, Maharashtra, India. 

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

Connect us via Social Media Channels:

LinkedIn  Facebook  Twitter Blogs

Global Legal Cannabis Market Analysis Report 2022: A $134.4 Billion Industry by 2030, Growing at a CAGR of Over 25%

0

Dublin, Sept. 26, 2022 (GLOBE NEWSWIRE) — The “Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Marijuana, Hemp), by Derivative (CBD, THC), by End Use (Medical Use, Recreational Use, Industrial Use), by Region, and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.

The global legal cannabis market size is expected to reach USD 134.4 billion by 2030 and is expected to expand at a CAGR of 25.3% from 2022 to 2030

The increased legalization across different nations of the usage of cannabis-derived products has gained a lot of popularity. Medical cannabis-based has been used in the treatment of various indications like epileptic seizures, nausea related to chemotherapy, anxiety, and other brain-related diseases.

Several studies are being conducted for CBD products in various indications. The medical fraternity has slowly increased acceptance of medical cannabis as well as marijuana and its derivatives owing to its legalization by the governments. Some countries like Canada, the U.S., and Uruguay have legalized its recreational use along with medicinal use.

Adult use and recreational use of marijuana is readily available in some of the countries’ markets, thereby increasing adoption and market growth. The COVID-19 pandemic has impeded the growth of the market. Supply chain disruptions and a surge in panic buying scenarios led to the increase in the demand-supply gap, thereby affecting the market growth. However, it is expected to grow post-pandemic with the increased support from governments and ever-increasing demand.

Based on source, the marijuana segment accounted for the largest revenue share of over 70.0% in 2021 and is expected to exhibit the fastest growth rate during the forecast period. Marijuana is easily available and consumers are becoming more aware of its therapeutic properties alongside the more traditional recreational uses.

It has been seen to reduce stress and relieve pain, thereby improving sleep irregularities. The decriminalization and legalization of marijuana usage have resulted in a marked reduction in illegal activities surrounding marijuana. CBD is quite potent when it comes to derivatives of the cannabis plant, thus it has emerged as the largest derivative segment with a revenue share of over 65.0% in 2021.

The adoption of CBD-based products is increasing rapidly owing to the non-psychoactive nature of the derivative, thereby fueling market growth. In addition, positive attitudes of the medical fraternity toward CBD-based medicines are further propelling the segment growth.

In addition, the others segment is anticipated to grow at the fastest rate during the forecast period owing to rising awareness and acceptance regarding the derivatives, along with increasing geographies sanctioning the use of various cannabinoids for medical and other purposes.

North America dominated the market with a revenue share of over 65.0% in 2021 owing to increasing acceptance of cannabis for medical purposes across the region and changing consumer perception toward cannabis. In addition, the presence of prominent cannabis companies in the North American region is boosting the market growth.

Moreover, the Asia region is anticipated to grow at the fastest rate owing to the increasing number of countries sanctioning the use of cannabis, mainly for medical purposes.

Legal Cannabis Market Report Highlights

  • The market growth can be attributed to the increasing legalization of cannabis across the globe.
  • The marijuana source segment dominated the market in 2021 owing to the increasing adoption of marijuana for medical as well as adult use.
  • The CBD derivative segment dominated the market in 2021 owing to the increasing number of countries sanctioning the use of CBD for medical as well as other purposes.
  • by end use, the medical use segment dominated the market in 2021 owing to the rising geriatric population and increasing demand for cannabis for various medical purposes such as the management of chronic pain, mental disorders, chemotherapy-induced nausea and vomiting, and neurological disorders.
  • North America dominated the market in 2021 owing to the growing demand and positive attitude toward cannabis in this region.

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Global Legal Cannabis Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Global Legal Cannabis Industry: History Of Medical Use Of Cannabis
3.5 Global Legal Cannabis Industry: History Of Industrial Use Of Cannabis
3.6 Global Legal Cannabis Industry: Number Of Clinical Trials, by Region
3.7 Global Legal Cannabis Industry: Legalization Timeline
3.7.1 Legalization Landscape (Timeline)
3.7.2 U.S. Legalization Landscape
3.7.3 Global Legal Cannabis Regulatory Scenario, by Country
3.7.3.1 U.S.
3.7.3.1.1 Overview
3.7.3.1.2 Cultivation/Production
3.7.3.1.3 Regulatory Bodies Involved
3.7.3.2 Canada
3.7.3.3 Germany
3.7.3.4 Italy
3.7.3.5 Croatia
3.7.3.6 The Netherlands
3.7.3.7 Czech Republic
3.7.3.8 Poland
3.7.3.9 Switzerland
3.7.3.10 Australia
3.7.3.11 Uruguay
3.7.3.12 Colombia
3.7.3.13 Argentina
3.7.3.14 Chile
3.7.3.15 Mexico
3.7.3.16 Israel
3.8 Global Legal Cannabis Industry: Consumption Pattern Analysis, by Region
3.8.1 Consumption Pattern Analysis, by Region
3.8.2 Estimated Number Of Cannabis Users From 2016 To 2026, by Country
3.8.3 Estimated Number Of Medical Marijuana Users From 2016 To 2026, by Country
3.9 Global Legal Cannabis Industry: Potential Trade Opportunity
3.9.1 Trade Opportunity Analysis, by Region
3.9.2 Global Legal Cannabis Trade Route
3.9.3 Global Hemp Trade Route
3.9.4 Countries Importing and Exporting Medical Cannabis (Flower)
3.9.5 Countries Importing and Exporting Hemp Seeds
3.9.6 Countries Importing and Exporting Hemp Seed Oil
3.10 Global Legal Cannabis Industry: Seed To Shelf Story
3.10.1 Section Description
3.10.1.1 Cultivators and Growers
3.10.1.2 Manufacturers and Producers
3.10.1.3 Testers
3.10.1.4 Wholesalers and Distributors
3.10.1.5 Retailers
3.10.2 Supply Chain Analysis
3.10.2.1 Profit Margin Estimation
3.11 Global Legal Cannabis Industry: Country Case Studies
3.11.1 U.S.
3.11.1.1 Legalization Of Cannabis
3.11.1.2 Reason For Legalization
3.11.1.3 Scenario After Legalization and Consumer Attitudes
3.11.1.4 Competitive Landscape Post Legalization
3.11.2 Canada
3.11.3 Thailand
3.11.4 South Africa
3.11.5 Uruguay

Chapter 4 Global Legal Cannabis Market: Source Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 Global Legal Cannabis Market: Source Movement Analysis, (USD Million) 2021 & 2030
4.2.1 Marijuana
4.2.1.2 Flowers
4.2.1.3 Oil and Tinctures
4.2.2 Hemp
4.2.2.2 Hemp CBD
4.2.2.3 Supplements
4.2.2.4 Industrial Hemp

Chapter 5 Global Legal Cannabis Market: Derivative Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Global Legal Cannabis Market: Derivative Movement Analysis, USD Million, 2021 & 2030
5.2.1 CBD
5.2.2 THC
5.2.3 Others

Chapter 6 Global Legal Cannabis Market: End-Use Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 Global Legal Cannabis Market: End-Use Movement Analysis, USD Million, 2021 & 2030
6.2.1 Medical Use
6.2.1.1 Medical Use Market Estimates and Forecasts, 2016 – 2030 (USD Million)
6.2.1.2 Cancer
6.2.1.3 Chronic Pain
6.2.1.4 Depression and Anxiety
6.2.1.5 Arthritis
6.2.1.6 Diabetes
6.2.1.7 Glaucoma
6.2.1.8 Migraines
6.2.1.9 Epilepsy
6.2.1.10 Multiple Sclerosis
6.2.1.11 Aids
6.2.1.12 Amyotrophic Lateral Sclerosis
6.2.1.13 Alzheimer’s
6.2.1.14 Post Traumatic Stress Disorder (Ptsd)
6.2.1.15 Parkinson’s
6.2.1.16 Tourette’s
6.2.1.17 Others
6.2.2 Recreational Use
6.2.3 Industrial Use

Chapter 7 Global Legal Cannabis Market: Competitive Analysis
7.1 Company Market Position Analysis
7.2 Strategic Framework

Chapter 8 Global Legal Cannabis Market: Regional Estimates & Trend Analysis: by Source, Derivative, and End Use
8.1 Regional Market Snapshot
8.2 Global Legal Cannabis Market: Regional Movement Analysis, USD Million, 2021 & 2030, USD Million

Chapter 9 Competitive Landscape

  • Gw Pharmaceuticals, plc
  • Aurora Cannabis, Inc.
  • Aphria, Inc. (Prior to Merger With Tilray)
  • Cronos Group
  • Tilray
  • Sundial Growers, Inc.
  • Insys Therapeutics, Inc.
  • the Scotts Company LLC
  • Vivo Cannabis Inc.
  • Cara Therapeutics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/fkj2wj

Attachment


Global Polyethylene Market: Analysis By Demand, By Production, By Product Density, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2027

0

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Polyethylene Market: Analysis By Demand, By Production, By Product Density, By Application, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2027” – https://www.reportlinker.com/p06318349/?utm_source=GNW
In 2021, the global polyethylene market was valued at US$139.95 billion, and is probable to reach US$186.16 billion by 2027. Also, global polyethylene market by demand reached 109.32 million tonnes in 2021 and is anticipated to reach 140.01 million tonnes by 2027.

Growth and expansion of industries like electrical & electronics, packaged food & beverages and automotive in most of the nations is likely to impact global polyethylene market. Upsurge in disposable income and increasing single-person households would impact demand for polyethylene in the coming years. The polyethylene market is projected to grow at a CAGR of 4.87%, during the forecast period of 2022-2027. In 2021, the global polyethylene market by production stood at 108.69 million tonnes and is forecasted to grow to 134.84 million tonnes by 2027.

Market Segmentation Analysis:

By Product Density: The report splits the global polyethylene market into three different product density: High Density Polyethylene (HDPE), Low Density Polyethylene (LDPE) and Linear Low Density Polyethylene (LLDPE). The High Density Polyethylene (HDPE) segment held approximately 43% of the share of the polyethylene market in 2021. The HDPE market experienced growth in the historical years, due to several factors such as expanding end-use industry, growing demand for polyethylene and rise in technological advancements in production of HDPE.

By Application: The report divides the global polyethylene market into five applications: Packaging, Construction, Household, Agriculture and Others. Packaging segment held the maximum share of 60% in the global polyethylene market. The growing food and beverages industry and growing concern towards the environment is primarily boosting the demand for polyethylene packaging.

By Region: According to this report, the global polyethylene market can be divided into four major regions: Asia Pacific (China, Japan, India, South Korea and Rest of Asia Pacific), North America (The US, Canada and Mexico), Europe (Germany, UK, France, Spain, Italy and Rest of Europe), and Rest of the World. The Asia Pacific polyethylene market enjoyed the market share of 51% in 2021, primarily owing to inexpensive and affordable quality of polyethylene to most producers who use polyethylene as a raw material for other plastic products.

While China continues to be a prominent region of Asia Pacific’s polyethylene market, accounting for the rising trend of online purchase of goods and rapid industrialization leading to a surge in demand for packaging material.

Global Polyethylene Market Dynamics:

Growth Drivers: Packaged food improves the shelf life of product, provides relevant information about its ingredients along with convenience of consumption to customers. High-density polyethylene (HDPE) is used in food packaging of products like squeeze butter, chocolate syrups, vinegar, milk jugs etc. Thus, creating demand for polyethylene. Further, the market is expected to increase due to escalating single-person household, upsurge in e-commerce sales, rising urbanization, surge in disposable income, surging application of polyethylene in agriculture, etc.

Challenges: The polyethylene production process mainly begins with petroleum, commonly referred to as crude oil. The use of crude oil as a raw material in the manufacturing of polyethylene indicates that any changes in price of crude oil would impact demand and price of polyethylene. Some other challenges that polyethylene market face are degrading impact on environment, etc.

Trends: A major trend gaining pace in polyethylene market is increasing demand for plastic films. The demand for plastic films is expected to positively impact polyethylene market as it is utilized in the plastic film manufacturing process. Plastic films are used in various applications such as plastic bags, packaging, photographic film and labels. More trends in the market are believed to augment the growth of polyethylene market during the forecasted period include rising cultivation of cannabis (Hemp & Marijuana), etc.

Impact Analysis of COVID-19 and Way Forward:

The outbreak of the COVID-19 pandemic increased polyethylene use. The quick development in demand for online sales channels in numerous industries such as food and beverages, consumer goods, and pharmaceuticals has greatly boosted polyethylene packaging use. Polyethylene’s versatility, strength, low cost, and light weight made it a popular packaging material, particularly for food and beverage products. Furthermore, the fast rise of online food delivery services has greatly increased demand for polyethylene packaging. Polyethylene has negative environmental effects, yet its use is predicted to increase significantly due to its widespread use in numerous industries throughout the world.

Competitive Landscape and Recent Developments:

The polyethylene market is fragmented with the presence of few number of players dominating worldwide. Key players of the polyethylene market are:

LyondellBasell Industries
SABIC
Repsol Group
ExxonMobil Corporation
INEOS Group Holdings S.A.
MOL Group
The Dow Chemical Company
Borealis AG
Reliance Industries Limited
Braskem S.A
LG Corporation (LG Chem Ltd.)
Borouge
Formosa Plastics Corp
Chevron Phillips Chemical Co.
China Petrochemical Corporation (SINOPEC)

In July 2020, Dow Chemicals and Thong Guan collaborated to introduce new bio-based product series of polyethylene that targeted to serve the Asia Pacific region’s rapidly growing demand for the polyethylene. Also, In May 2020, UPM Raflatac introduced its new line of Forest Film products, which is produced from the post-consumer recycled plastics and it is used in the packaging of products. This strategy aimed at reducing the carbon footprint that will also provide a competitive advantage to the company.
Read the full report: https://www.reportlinker.com/p06318349/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


Cannabis Extraction: Global Markets

0

New York, Sept. 26, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Cannabis Extraction: Global Markets” – https://www.reportlinker.com/p06320638/?utm_source=GNW
The scope of this report is limited and covers global markets for cannabis extraction equipment and services only.

The market is divided by equipment, services, methods and region. Projected and forecasted market size estimates are constant U.S. dollars that have not been adjusted for inflation.

This report provides market insights into the global cannabis extraction market, focusing on the U.S., Europe, Asia and the top cannabis extraction companies in those countries. It provides information, including market size, expected growth rates, market drivers, restraints, and other trends and developments.

This report should serve as an analytical and informational business tool with the primary purpose of examining growth in the overall cannabis extraction market, growth in the individual segments of the cannabis extraction industry, subcategories within those segments, new developments in the market, current research and future opportunities in the cannabis extraction industry.

Beyond this, each segment and subsegment of cannabis extraction is examined. Growth rates and reasons for growth in each non-alcoholic beverage segment are provided. This report studies the following segments –
– Equipment subcategories –
– Cannabis extraction equipment.
– Cannabis analytical testing equipment.
– Services subcategories –
– Cannabis extraction services.
– Cannabis analytical testing services.
– Cannabis regulatory and compliance services.
– Method subcategories –
– CO2-based extraction.
– Ethanol based extraction.
– Hydrocarbons based extraction.
– Vegetable oils based extraction.
– Other extraction methods.

The regional markets covered are North America, Europe, Asia Pacific, South America, and the Middle East and Africa.This report also discusses the major players in each regional market for cannabis extraction.

It explains the foremost market drivers of the global cannabis extraction market, current trends within the industry, and the regional dynamics of the cannabis extraction market. The report concludes with detailed profiles of major international vendors in the cannabis extraction industry.

Report Includes:
– 51 data tables and 113 additional tables
– A comprehensive overview of the global market for cannabis extraction equipment and services
– Analyses of the global market trends, with historic market revenue for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
– Estimation of the actual market size for cannabis extraction industry, market forecast, and corresponding market share analysis by equipment, services, extraction method, and geographic region
– Coverage of the technological, economic and business considerations of the cannabis extraction market with analyses and forecasts provided for global markets
– Discussion of current and future market potential for market for cannabis extraction tools and services, along with a supply chain analysis, industry regulations, and other forces relevant to this market
– Regional market outlook with select sub-regional breakdowns for countries with promising market demands for cannabis extraction and applications thereof
– Emphasis on the trends and developments in the market, global competitive landscape analysis, and innovations in the cannabis industry
– Descriptive company profiles of the major cannabis extraction companies, including Aptia Engineering, Danaher Corp., Eurofins Scientific, Neptune Wellness Solutions, PerkinElmer Inc., Root Sciences and Sage Analytics

Summary:
A cannabis extract is a concentration made from cannabis that has been dissolved in a solvent.Although the terms “extract” and “concentrate” are commonly used interchangeably, extracts are not all concentrates, but concentrates are all extracts.

While concentrates can be generated using a variety of mechanical techniques as well as the use of a solvent, extracts are the only type of concentrate that requires the use of a solvent. Butane, propane, ethanol and supercritical carbon dioxide (CO2) are the most frequent solvents used to generate a cannabis extract.

The wide range of products known as cannabis extracts contain more cannabinoids than the actual cannabis plant.When consumed, cannabinoids, which are chemical components of cannabis, have an impact on both the body and mind.

The most well-known cannabinoid, THC (tetrahydrocannabinol), is the one that results in euphoria and intoxication (or high).Although more research is required, the nonpsychoactive cannabinoid CBD (cannabidiol) has some potential as a medicine.

Cannabis extracts can contain a wide range of THC and CBD concentrations. While some extracts have a THC content of up to 99%, others are mostly CBD with very little THC.
Read the full report: https://www.reportlinker.com/p06320638/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


CENTR Brands Corp. Fiscal Year 2022 Results Net Sales Growth of over 240%

0

Vancouver, British Columbia–(Newsfile Corp. – September 24, 2022) – CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the “Company”) (CENTR®, or CENTR Instant), one of the fastest-growing premium functional wellness drink brands in North America, today announced its audited financial results for the year ended May 31, 2022. Selected comparative financial information is set forth below with the full financial statements for the year and the related management’s discussion and analysis available under the Company’s SEDAR profile at www.sedar.com. All amounts are expressed in United States Dollars, unless otherwise stated:

Description Year Ended May 31, 2022
($)
Year Ended May 31, 2021
($)
Net sales 1,853,902 762,547
Net income (loss) and
comprehensive income (loss) (1)(2)
484,939 (14,257,039)
Basic and diluted earnings (loss) per share 0.01 (0.22)

 
(1) For the year ended May 31, 2022, net income and comprehensive income includes a non-cash gain of $5,879,278 for the revaluation of warrants as a liability for accounting purposes.
(2) For the year ended May 31, 2021, net loss and comprehensive loss includes non-cash losses of $8,014,811 for the revaluation of warrants as a liability for accounting purposes and $2,240,873 for the vesting of restricted share units.

“We continue to be excited about CENTR’s leadership in the high-growth sparkling CBD beverage category. We expect to continue to deliver solid results and best-in-class performance as this category continues to evolve and activate in additional markets throughout the U.S,” said Company CEO, Arjan Chima. “We look forward to CENTR’s continued growth within the CBD sparkling water category. Additionally, we are excited at the tremendous growth prospects with the launch of CENTR Enhanced, the Company’s first non-CBD product meeting consumer demand in the high-growth, multi-billion-dollar functional beverage market, which will be available to consumers throughout North America later this calendar year. “We continue to be pleased with the strong, triple-digit, growth rates CENTR has been achieving year-over-year and look forward to similar growth as CENTR evolves beyond CBD into a leading supplier in the life-style oriented functional wellness market,” said Company President & CFO, David Young.

About CENTR Brands Corp.

CENTR Brands Corp. is one of North America’s leading functional wellness beverage companies, and maker of the #1 selling CBD beverage brand in the United States, according to Brightfield Research. The Company develops and markets non-alcoholic, functional ingestibles for the global market. The Company produces CENTR, CENTR Sugar Free, both sparkling, low-calorie CBD beverages and CENTR Instant, a family of on-the-go, adaptogen-based CBD powders.

For more information on CENTR Brands visit findyourcentr.com or contact us at [email protected]. Be sure to follow us on social media: @findyourcentr. Consumers that do not yet have a local CENTR Brands retailer can visit our online store at: findyourcentr.com/shop.

On behalf of the Board,

CENTR BRANDS CORP.
/s/ Arjan Chima
Arjan Chima, Chief Executive Officer

This press release may contain “Forward-Looking Statements” within the meaning of applicable Canadian securities laws. Forward-looking statements are not comprised of historical facts. Forward- looking statements include estimates ​and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the ​Company or management expects a stated condition or result to occur. Forward-looking statements may be ​identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or ​​”plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by ​their very nature they involve inherent risks and uncertainties. Although these statements are based on information ​currently available to the Company, the Company provides no assurance that actual results will meet management’s ​expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual ​events, results, performance, prospects and opportunities to differ materially from those expressed or implied by ​such forward-looking information​. Forward-looking information in this news release includes, but is not limited to, the Company’s intentions regarding ​its objectives, goals or future plans and statements, including with respect to the value proposition the Company offers to consumers, the Company’s ability to capitalize on global health & wellness trends, its ability to grow revenue opportunities and improve returns to its shareholders, the Company’s positioning in the emerging health beverage market and the Company’s ability to drive sustainable, industry-leading growth.​ Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138371

Hempacco with Partners Rick Ross and James Lindsay Launch Hemp Hop Smokables

0

Hemp Hop Smokables Are Also Featured at the Boss Up Conference 2022 with Rick Ross

San Diego, California–(Newsfile Corp. – September 23, 2022) – Hempacco Co., Inc. (NASDAQ: HPCO) (“Hempacco” or the “Company”), a hemp smokables company Disrupting Tobacco’s™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the official release of Hemp Hop Smokables on www.HempHop.shop.

Consumers can buy Hemp Hop Smokables online at www.HempHop.shop and get Buy One Get One FREE with code HPCO. Its Hemp Hop joint venture partners, hip hop icon Rick Ross and Rap Snacks, Inc. founder and CEO James Lindsay, presented the Hemp Hop Smokable products at the Boss Up Conference, September 17-19, 2022.

“We’re ready to start offering Hemp Hop Hemp Cigarettes to wholesale distributors,” said Jorge Olson, Co-founder and CMO of Hempacco. “With Rick Ross and James Lindsay spearheading the sales, distribution, and marketing, it will be a wonderful consumer experience for the consumers. James Lindsay is also a wholesale distribution veteran and is ready to present the products to all of his Rap Snacks network of distributors all over the country,” concluded Jorge Olson.

Rick Ross is known as one of hip-hop’s biggest moguls. The Florida-bred rapper boasts a healthy slew of investments, including his most prominent venture as a franchise owner of multiple Wingstop locations throughout the country. He’s also the CEO of his very own label Maybach Music Group (MMG), which is home to artists such as Wale, Meek Mill, and more.

Now Ross, and his partner Lindsay, are helping to change the scope of the entrepreneurial space. Ross and Lindsay believe many business owners are one connection away from getting to the next level and through the Boss Up Conference, they are bringing the right entrepreneurs together in the same room to help accelerate their growth.

“It’s fantastic to team up with my partner, Rick Ross, to mentor black entrepreneurs wanting to scale their business and become mentors to the new generation of your business leaders. Sculpting and participating in the success of others is one of my big passions,” said James Lindsay, CEO and Founder of Rap Snacks, Inc. and co-founder of Hemp Hop Smokables.

James Lindsay is a lifetime entrepreneur and wholesale distribution expert. Before he started Hemp Hop Smokables, James already has national distribution for his Rap Snacks brands, including major retailers like Walmart, and thousands of convenience stores all around the country. Rap Snacks currently offers over 40 products including potato chips, ramen noodles, and lemonades.

This year’s annual event featured the recently launched Hemp Hop Smokables brand, a 50/50 joint venture formed with Hempacco, focused on developing, manufacturing, and marketing an expanding consumer goods line of CBD hemp functional cigarettes and hemp wrap rolling papers.

About Hempacco

Hempacco Co., Inc.’s goal is Disrupting Tobacco’s™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand.

Hempacco’s operational segments include:

  1. Manufacturing of smokables and hemp rolling paper

  2. Smokable technology development

  3. The Real Stuff™ brand of functional smokables and rolling paper

  4. Cheech and Chong Hemp Cigarettes and Hemp Hop Smokables with Rick Ross

Learn more at www.hempaccoinc.com

Order products at www.realstuffsmokables.com

Safe Harbor Statement

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the “SEC”) by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

For investor inquiries, please contact:

Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138227